|Day Low/High||216.03 / 219.03|
|52 Wk Low/High||104.28 / 242.62|
Let's see if we can identify the next sustained move.
Changes will come as they move their wine and spirits business to the 'high end', and develop the activities of Canopy Growth, which promises cannabis-infused drinks.
The risk is that the chief design officer's departure will cause technical issues in Apple's chart.
Some key names are set to release their latest earnings results.
Canopy Growth's latest financial results offer a reality check.
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
I just wrote a piece for Real Money covering fourth-quarter earnings for Canopy Growth , the name most analysts refer to as the top cannabis play in Canada. As you have likely seen by now, the company's operational loss for the quarter printed ugly...
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Oh, by the way, Constellation, for those who've forgotten, holds a 38% stake in Canopy Growth.
There is certainly too much to ignore about STZ for the majority of analysts.
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
What I do know is that TSLA now faces a tumultuous uphill battle in order to meet its full year guidance.
I am upping my Apple price target.
What to look for when Dave & Buster's and Constellation Brands report results.
I've noted a few names from the comments that may be involved in the CBD-infused beverage market in the form of New Age Beverage Corp. and Constellation Brands . While I'm a big supporter in the potential of CBD and cannabis, I have my reservations ...
Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.